Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertensionheart failure and percutenous coronary interventions (PCI).

FDA Clears Zilver Vena Venous Self-Expanding Stent
News | Venous Therapies | February 22, 2021
February 22, 2021 — The U.S. Food and Drug Administration (FDA) recently cleared the Cook Medical Zilver Vena Venous...
A comparison showing angiography and optical coherence tomography (OCT) views of an undilated mid right coronary artery calcified lesion, post dilation with the Shockwave intravascular lithotripsy system, and the final result after stenting. The technology allows calcified lesions to be broken up without the need for vessel trauma caused by high pressure balloons or atherectomy. 

A comparison showing angiography and optical coherence tomography (OCT) views of an undilated mid right coronary artery calcified lesion, post dilation with the Shockwave intravascular lithotripsy system, and the final result after stenting. The technology allows calcified lesions to be broken up without the need for vessel trauma caused by high pressure balloons or atherectomy.

Feature | Balloon Catheter | February 17, 2021
February 17, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Shockwave Medical's Intravascular...

SpectraWave is developing a a new intravascular imaging system that combines two currently available modalities. This likely includes optical coherence tomography (OCT), left, which can define structures within the vessel and vessel wall.  Near infrared spectroscopy (NIRS), right, enables a spectral chemical analysis of the vessel walls to show areas of high lipid content, and specifically can identify lipid-core plaques that are associated with heart attack-causing plaque ruptures.

News | Cath Lab | February 16, 2021
February 16, 2021 – SpectraWave Inc. announced a $13.2 million series A-2 financing to support completion of product...
product comparison charts for cardiology and health IT systems
Feature | February 12, 2021
Diagnostic and Interventional Cardiology (DAIC) magazine maintains more than 50 comparison charts of product...
InspireMD's MicroNet embolic protection mesh on stents is designed to prevent emboli during carotid stenting.

InspireMD's MicroNet embolic protection mesh on stents is designed to prevent emboli during carotid stenting.

News | Embolic Protection Devices | February 09, 2021
February 9, 2021 — InspireMD Inc., developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke...
The EndoWays disposable robotic system for cath lab procedural navigation. EndoWays, developer of a disposable robotic system for the cath lab, announced the completion of an acquisition of a majority of its shares by Ascendum

The EndoWays disposable robotic system for cath lab procedural navigation.

News | Robotic Systems | February 09, 2021
February 9, 2021 — EndoWays, developer of a disposable robotic system for the cath lab, announced the completion of an...
Teleflex Acquires Hemostatic Products Vendor Z-Medica
News | Hemostasis Management | February 08, 2021
February 8, 2021 — Teleflex Inc. said it recently completed its acquisition of Z-Medica LLC, an industry-leading...
Videos | Cath Lab | February 04, 2021
Cindy Grines, M.D., MSCAI, FACC, president of the Society for Cardiovascular Angiography and Interventions (SCAI), and...
Patients with bicuspid, or two-leaflet, aortic valves who undergo transcatheter aortic valve replacement (TAVR) procedures had a high rate of success and low risk of death or disabling stroke at 30 days, according to new data presented at the American College of Cardiology (ACC) 2020 Scientific Session.
News | Heart Valve Technology | February 04, 2021
February 4, 2021 — Transcatheter aortic valve replacement (TAVR) has historically only been used with caution in the...
An interventional radiologist consults with a patient in an out patient cath lab at a Modern Vascular clinic. The company is building several out patient clinics to capture a share of the interventional market for peripheral artery disease (PAD) catheter-based therapies. 

An interventional radiologist consults with a patient in an out patient cath lab at a Modern Vascular clinic. The company is building several out patient clinics to capture a share of the interventional market for peripheral artery disease (PAD) catheter-based therapies. 

News | Cardiovascular Business | February 03, 2021
February 3, 2021 — Modern Vascular is a medical group that has 13 outpatient cath lab clinics to treat peripheral...
The Occlutech implantable Atrial Flow Regulator (AFR) maintains an interatrial shunt with a predetermined diameter allowing for controlled blood flow from the left to the right atrium enabling the left atrium to decompress and lower left atrial pressure. This reduced left atrial pressure reduces heart failure symptoms and improves exercise tolerance.

The Occlutech implantable Atrial Flow Regulator (AFR) maintains an interatrial shunt with a predetermined diameter allowing for controlled blood flow from the left to the right atrium enabling the left atrium to decompress and lower left atrial pressure. This reduced left atrial pressure reduces heart failure symptoms and improves exercise tolerance.
 

News | Heart Failure | January 27, 2021
January, 27, 2021 — The U.S. Food and Drug Administration (FDA) has granted Occlutech a Breakthrough Device designation...
The Pedra Blood Perfusion Index tracks real-time changes in foot tissue perfusion attendant with balloon inflation and deflation during an angioplasty procedure.

The Pedra Blood Perfusion Index tracks real-time changes in foot tissue perfusion attendant with balloon inflation and deflation during an angioplasty procedure.

News | Peripheral Artery Disease (PAD) | January 26, 2021
January 26, 2021 — Pedra Technology, a privately held company, announced today that the U.S. Food and Drug...
FDA Clears Boston Scientific Synergy Megatron Drug-eluting Stent for Proximal, Fibrotic and Calcified Lesions
News | Stents Drug Eluting | January 26, 2021
January 26, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific's Synergy Megatron Drug-...
An example of 3-D computer aided design (CAD) software from Materialise being used at Henry Ford Hospital to evaluate left ventricular outflow tract (LVOT) obstruction from a Sapian TAVR valve virtually implanted in the mitral valve position. Henry Ford uses both 3-D printing and CAD to plan and guide complex structural heart procedures. 

An example of 3-D computer aided design (CAD) software from Materialise being used at Henry Ford Hospital to evaluate left ventricular outflow tract (LVOT) obstruction from a Sapian TAVR valve virtually implanted in the mitral valve position. Henry Ford uses both 3-D printing and CAD to plan and guide complex structural heart procedures. 

Feature | Medical 3-D Printing | January 24, 2021 | By Dave Fornell, Editor
With increasing complexity of interventional structural heart disease and congenital heart disease interventions, 3-D...
A new CMS national coverage determination for reimbursement for MitraClip significantly expand access to transcatheter mitral valve repair procedures for secondary mitral regurgitation.
News | Heart Valve Technology | January 20, 2021
January 20, 2021 — The U.S. Centers for Medicare and Medicaid Services (CMS) revised its National Coverage...